Lava Therapeutics Nv Reports Results For The Quarter Ended In March: Earnings Summary

LAVA Therapeutics NV

20/05/2021 13:37

* LAVA Therapeutics NV  LVTX.OQ  reported a quarterly adjusted
loss of $12.27​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 80 cents per share.
* Revenue was $1.11 million​;  analysts expected zero. 
* LAVA Therapeutics NV's reported EPS for the quarter was a loss
of $12.27​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* LAVA Therapeutics NV shares had fallen by 18.6% this quarter.
* The company reported a quarterly loss of $19.97 million.
* Wall Street's median 12-month price target for LAVA
Therapeutics NV is $23.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 20 at 12:37 p.m. GMT.
​All figures in US dollars